Dora Bibila, Commercialization Strategy Lead, Corval
Advertisement
Articles by Dora Bibila, Commercialization Strategy Lead, Corval
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Redefining Obesity Success in the GLP-1 Era: Q&A with Brian Hilberdink
2
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010
3
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
4
Additive Manufacturing's Application in Pharma and Biotech
5